A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington's Disease

  • Kempster, Peter (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/47254/MonH-2018-154959(v1)
SSA: SSA/47254/MonH-2019-167104(v1) dated 4 March 2019
Monash Health Ref: RES-18-0000639A
Effective start/end date3/06/192/06/24


  • Clinical trial
  • treatment efficacy
  • Huntington's disease